New York, New York 10001


Purpose:

Persons with dementia and their caregivers are often cared for in the community through home healthcare (HHC). While these patients and their caregivers need significant help and often have difficulty maintaining their quality of life, home healthcare clinicians are often unprepared to care for this population. This study will therefore examine the ability of an integrated, multi-pronged evidence-based practice intervention for home healthcare registered nurses, occupational therapists and physical therapists, the DSM-H, to improve the quality of care and quality of life for persons with dementia and their family caregiver. The investigators will enroll persons with dementia and their family caregiver upon admission to the HHC agency and examine their quality of life over 60 days following admission, comparing those who receive the intervention to those who serve as controls.


Study summary:

The Dementia Symptom Management at Home (DSM-H) Program is an integrated bundled implementation science intervention to improve interprofessional care in home healthcare (HHC). It consists of training, assessment instruments, patient-caregiver centered care plans and workflow changes. The investigators will perform a cluster randomized controlled clinical trial at a single, urban, non-profit HHC agency, randomizing care teams to either be trained in performing the intervention or serve as controls. The aims of this program are to examine the efficacy of this program to: Aim 1: Measure the effects of DSM-H on pain, neuropsychiatric symptoms, and caregiver rated QOL in the person with dementia receiving HHC. Aim 2: Assess the effects of DSM-H on QOL, burden and depression for the informal caregiver of persons with dementia receiving HHC. Aim 3: Assess the effects of DSM-H on the number of emergency room visits and hospital admissions.


Criteria:

Inclusion Criteria: - patient-caregiver dyad admitted to the HHC agency - Patients must be 65 or older and speak English and/or Spanish. - Patient must have an informal caregiver who is at least 18 years old and spends at least 8 hours per week with the patient. - Patients must score greater than 4 on the cognitive subscale of the Healthy Aging Brain Care Monitor signifying at least mild impairment Exclusion Criteria: - Patients with concomitant axis I disorders other than dementia, depression, adjustment disorders, sleep disorders. - Patients being seen only in the behavioral health unit without another skilled need.


NCT ID:

NCT02482623


Primary Contact:

Principal Investigator
Abraham A Brody, RN, PhD, GNP-BC
Assistant Professor

Abraham A Brody, RN, PhD, GNP-BC
Phone: 212-992-7341
Email: ab.brody@nyu.edu


Backup Contact:

N/A


Location Contact:

New York, New York 10001
United States

MaryLou Harren, RN
Phone: 347-556-7855
Email: mharren@jewishhome.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.